Manuel Ferrandiz Zavaler

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

E. Silverman, A. Martini, R. Burgos-Vargas, 2020, Arthritis & rheumatology.